<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08904085000448</udiDi>
    <basicUdiDi>B-08904085000448</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1045</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:15.359Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000431</udiDi>
    <basicUdiDi>B-08904085000431</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1044</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:14.171Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000424</udiDi>
    <basicUdiDi>B-08904085000424</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1043</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:12.962Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000356</udiDi>
    <basicUdiDi>B-08904085000356</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1036</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:11.759Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000240</udiDi>
    <basicUdiDi>B-08904085000240</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:04.559Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000233</udiDi>
    <basicUdiDi>B-08904085000233</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:03.366Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000226</udiDi>
    <basicUdiDi>B-08904085000226</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1002</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:02.161Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000219</udiDi>
    <basicUdiDi>B-08904085000219</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1001</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:00.973Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000158</udiDi>
    <basicUdiDi>B-08904085000158</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1021</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:07:54.964Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000127</udiDi>
    <basicUdiDi>B-08904085000127</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1018</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:07:53.751Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000110</udiDi>
    <basicUdiDi>B-08904085000110</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1017</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:07:52.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000080</udiDi>
    <basicUdiDi>B-08904085000080</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1014</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:07:50.154Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000066</udiDi>
    <basicUdiDi>B-08904085000066</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1010</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:07:44.152Z</lastUpdated>
  </row>
</eudamedExport>